Skip to main content
Signal8

Pittman Scott M.

SEC insider (Form 3/4/5 filer). CIK 0001674752. Director & 10% Owner at Nuo Therapeutics, Inc. (AURX). 26 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in HOUSTON, TX.

Companies Pittman Scott M. has filed insider reports for

  • Nuo Therapeutics, Inc. (AURX): Director, 10% Owner
Pittman Scott M. profile photo

Pittman Scott M.

CIK: 0001674752

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)7 (26.9%)

Derivative conversions

Awards (A)16 (61.5%)

Compensation grants

Other (G, F, J, C, D, …)3 (11.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nuo Therapeutics, Inc. logo
AURX

Nuo Therapeutics, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (26 total)

  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Oct 6, 2026
    Award

    Second Restated Warrant (right to buy)

    Direct
    4.5K shares at avg. $1.50-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Oct 6, 2026
    Award

    Prepayment Restated Warrant (right to buy)

    Direct
    458 shares at avg. $1.50-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Jun 30, 2026
    Exercise
    Direct
    40K shares at avg. $1.00$40K
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Jun 30, 2026
    Tax Payment
    Direct
    39.6K shares at avg. $1.01$40K
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Jun 29, 2026
    Award

    Option to purchase common stock

    Direct
    30K shares-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    May 29, 2026
    Award

    Prepayment Restated Warrant (right to buy)

    Direct
    7.3K shares at avg. $1.50-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    May 29, 2026
    Disposition

    Prepayment Warrant (right to buy)

    Direct
    7.5K shares at avg. $1.50-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    May 29, 2026
    Award

    Interim Warrant (right to buy)

    Direct
    17.5K shares at avg. $1.50-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    May 29, 2026
    Disposition

    Second Warrant (right to buy)

    Direct
    36.8K shares at avg. $1.50-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    May 29, 2026
    Award

    Second Restated Warrant (right to buy)

    Direct
    17.5K shares at avg. $1.50-

1-10 of 26